1.17
5.88%
0.065
Dopo l'orario di chiusura:
1.17
Precedente Chiudi:
$1.105
Aprire:
$1.15
Volume 24 ore:
33,900
Relative Volume:
0.24
Capitalizzazione di mercato:
$46.47M
Reddito:
-
Utile/perdita netta:
$-74.56M
Rapporto P/E:
-0.5995
EPS:
-1.9516
Flusso di cassa netto:
$-60.27M
1 W Prestazione:
+6.36%
1M Prestazione:
+1.74%
6M Prestazione:
-36.76%
1 anno Prestazione:
-65.28%
Rallybio Corp Stock (RLYB) Company Profile
Nome
Rallybio Corp
Settore
Industria
Telefono
203- 859-3820
Indirizzo
234 CHURCH STREET, NEW HAVEN
Rallybio Corp Stock (RLYB) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2023-04-17 | Iniziato | H.C. Wainwright | Buy |
2023-04-10 | Iniziato | Wedbush | Outperform |
2022-12-09 | Iniziato | JP Morgan | Overweight |
2022-02-22 | Iniziato | JMP Securities | Mkt Outperform |
2021-08-23 | Iniziato | Cowen | Outperform |
2021-08-23 | Iniziato | Evercore ISI | Outperform |
2021-08-23 | Iniziato | Jefferies | Buy |
Mostra tutto
Rallybio Corp Borsa (RLYB) Ultime notizie
Rallybio's SWOT analysis: FNAIT treatment stock poised for growth amid challenges - Investing.com India
Data Demonstrating ENPP1 Inhibition as a Therapeutic Approach for Later-onset Hypophosphatasia Presented at the American Society for Bone and Mineral Research 2024 Annual Meeting - StockTitan
Rallybio reveals higher FNAIT risk across populations - Investing.com
Rallybio reveals higher FNAIT risk across populations - Investing.com India
Rallybio to Present Results of Epidemiological Analysis Demonstrating FNAIT Risk Across Racially and Ethnically Diverse Populations at the American Society of Human Genetics 2024 Annual Meeting - StockTitan
Rallybio Co. (NASDAQ:RLYB) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Rallybio announces board member resignation - Investing.com
Rallybio announces board member resignation - Investing.com India
Rallybio announces board member resignation By Investing.com - Investing.com UK
Dr. Kush Parmar Steps Down from Rallybio’s Board and Committee - TipRanks
Rallybio Corporation Announces Resignation of Kush Parmar as Member of Board and Chair of Nominating and Corporate Governance Committee, Effective October 31, 2024 - Marketscreener.com
RLYBRallybio Corporation Latest Stock News & Market Updates - StockTitan
Rallybio to Present Results of Epidemiological Analysis Demonstrating FNAIT Risk Across Racially and Ethnically Diverse Populations at the NORD Breakthrough Summit - Business Wire
Rallybio to Present Results of Epidemiological Analysis Demonstrating FNAIT Risk Across Racially and Ethnically Diverse Populations at the NORD Breakthrough Summit - StockTitan
Fierce Names Rallybio to the 2024 Fierce 50 List as an Innovation Honoree - Business Wire
Rallybio - FiercePharma
Fierce Names Rallybio to the 2024 Fierce 50 List as an Innovation Honoree - StockTitan
Rallybio stock plunges to 52-week low, hits $1.09 - Investing.com
Rallybio (NASDAQ:RLYB) Given “Buy” Rating at HC Wainwright - Defense World
Rallybio reiterated at Buy at H.C. Wainwright on FNAIT drug data - Investing.com
Rallybio advances RLYB212 to phase 2 for FNAIT prevention - Investing.com India
Rallybio advances RLYB212 to phase 2 for FNAIT prevention - Investing.com
Rallybio Announces Publication of RLYB212 Phase 1 Proof-of-Concept Study Results in Thrombosis and Haemostasis - Business Wire
We Think Rallybio (NASDAQ:RLYB) Needs To Drive Business Growth Carefully - Simply Wall St
Rallybio to Present at Upcoming Investor Conferences - Elk Valley Times
Rallybio to Present at Upcoming Investor Conferences - Business Wire
Rallybio (RLYB) Upgraded to Buy: What Does It Mean for the Stock? - MSN
Rallybio stock plunges to 52-week low at $1.09 amid market challenges - Investing.com Australia
HC Wainwright Comments on Rallybio Co.’s Q3 2024 Earnings (NASDAQ:RLYB) - Defense World
Rallybio stock plunges to 52-week low at $1.09 amid market challenges - Investing.com
Rallybio stock plunges to 52-week low at $1.09 amid market challenges - Investing.com UK
Rallybio (RLYB) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance Australia
Rallybio (RLYB) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
H.C. Wainwright lowers Rallybio shares target, sees potential in FNAIT treatment - Investing.com
H.C. Wainwright lowers Rallybio shares target, sees potential in FNAIT treatment - Investing.com Australia
H.C. Wainwright lowers Rallybio shares target, sees potential in FNAIT treatment - Investing.com India
Rallybio (NASDAQ:RLYB) PT Lowered to $6.00 - Defense World
H.C. Wainwright lowers Rallybio shares target, sees potential in FNAIT treatment - Investing.com UK
Is Rallybio (NASDAQ:RLYB) In A Good Position To Invest In Growth? - Yahoo Finance
Rallybio Reports Second Quarter 2024 Financial Results and Provides Business Updates - StockTitan
Rallybio stock plunges to 52-week low at $1.12 amid market challenges - Investing.com
31,294 Shares in Rallybio Co. (NASDAQ:RLYB) Bought by Acadian Asset Management LLC - Defense World
Brokerages Set Rallybio Co. (NASDAQ:RLYB) Target Price at $12.20 - MarketBeat
Rallybio co-founder joins another CT bioscience company board - Hartford Business Journal
Rallybio Co. (NASDAQ:RLYB) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
SpringWorks Therapeutics Appoints Dr. Martin Mackay to its Board of Directors - StockTitan
Rallybio Co. (NASDAQ:RLYB) Sees Large Drop in Short Interest - MarketBeat
Rallybio co-founder to step down as executive chairman, leave full-time role - Hartford Business Journal
Rallybio Corp announces executive transition plan - Investing.com
Rallybio Executive Chairman Announces Plans to Step Down - TipRanks
Short Interest in Rallybio Co. (NASDAQ:RLYB) Drops By 16.9% - MarketBeat
Rallybio Corp Azioni (RLYB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):